Pharmaceuticals roundup 2021

It’s been another dramatic, pandemic-dominated year for the pharmaceutical industry. At the turn of the year, mRNA-based Covid-19 vaccines from Pfizer­–BioNTech and Moderna had just started to reach the public’s arms. As we reach the close of 2021, several others have reached the market and, in many countries, booster programmes are rolling out, alongside approvals to immunise teenagers and young children.